Drug intelligence / Profile preview

Bronchostop

Development stage
Unknown
Lead developer
Kwizda Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Bronchostop is a traditional herbal medicinal product developed and marketed by Kwizda Pharma for the relief of coughs associated with the common cold. It features a dual-action formulation containing extracts of thyme (*Thymus vulgaris* and *Thymus zygis*) and marshmallow root (*Althaea officinalis*). Thyme extract serves as an expectorant and bronchodilator, facilitating the thinning and expulsion of thick phlegm in productive coughs. Marshmallow root extract contains mucilaginous polysaccharides that form a protective layer over the pharyngeal mucosa, providing a demulcent effect that soothes irritation and suppresses the urge to cough in dry, tickly coughs. Bronchostop is available over-the-counter in several oral formats, including syrups, lozenges, and pastilles, and is widely distributed across European markets.

Brand names
BronchostopBronchostop DuoBronchostop Sine
Other names
Thyme extract + Marshmallow root extract
02

Targets

SMPD1 (Acid sphingomyelinase)

Beyond the preview

Go deeper on Bronchostop.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronchostop.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call